Lp-PLA2 antibody
| 产品别名 |
PLA2G7 antibody Platelet-activating factor acetylhydrolase precursorantibody, LDL-PLA2 antibody, LP-PLA2 antibody, PAFAD antibody, PAFAH antibody |
产品参数
| 货号 |
SLS-217-01 |
| 克隆类型 |
L795YL |
| 亚型 |
IgG1 |
| 规格 |
1mg/支 |
| 浓度 |
2-3mg/ml |
| 配对 |
This antibody can be used for solid phase coating when paired with SLS-217-02. |
| 纯度 |
>95% pure(SDS-PAGE). |
| 批号 |
随货见 |
| 状态和缓冲液 |
0.01M PBS, 0.9% NaCl, pH 7.4 |
使用建议 & 方法学
| 应用 |
This product is only for the in vitro study, not intended for diagnostic use, please according to the laboratory standard operating procedures using. |
| 使用建议 |
Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. |
存储 & 安全
| 存储 |
Stored at 2-8°C short term, -20°C or colder long term. Avoid multiple freeze/thaw cycles. |
产品描述
PLA2G7(platelet-activating factor acetylhydrolase), also known as lipoprotein-associated phospholipase A2, is a phospholipase A2 enzyme. It is a secreted enzyme which catalyzes the degradation of platelet-activating factor to biologically inactive products. This protein is produced by inflammatory cells and hydrolyzes oxidised phospholipids in LDL. In the blood, PLA2G7 goes mainly with LDL and less than 20% is coupled with HDL. It is implicated in the development of atherosclerosis and is also a marker for cardiac disease. It might have a major physiologic effect in the presence of inflammatory bodily responses. Recombinant human PLA2G7 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography.
